Enable Injections

Enable Injections

Private
Cincinnati, OhioHealthcare & Life Scienceshttps://www.enableinjections.com

Last Round

Corporate Funding

Jan 7, 2026

Total Funding Raised

$325M

Company Overview

Enable Injections is a medical device company that specializes in on-body delivery systems for the subcutaneous self-administration of high-volume therapeutics, utilizing standard container closure systems for user-friendly and controlled injections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Health IoT, Pharma Supply Chain, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

wearable drug deliveryon-body injectorlarge volume drug deliverysubcutaneous drug deliverylarge volume injectorLVIpatient self-administrationat-home infusionIV-to-SC conversioncombination productbiologics deliverypharma partnershipsmedical device manufacturingmechanical infusion devicedrug transfer system

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enable Injections Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Enable Injections Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingJan 7, 2026
Series CJan 27, 2022
Series BOct 25, 2018
Series AOct 5, 2016

Key People

Founding team and executive leadership

Mike Hooven

President And CEO

Executive Team

David Kroekel

Chief Operating Officer

Executive Team

Matthew Huddleston

Executive Vice President Chief Technology Officer, Chief Commercial Officer

Executive Team

Tim Flaherty

Executive Vice President , Chief Financial Officer, Vice President-Finance, Chief Financial Officer

Executive Team

Enable Injections Investors

Notable investors and investment history

InvestorRounds
Magnetar CapitalSeries C
Partisan Management GroupSeries B
Squarepoint VenturesSeries C
CincyTechSeries A, Series B, Series C
GCM GrosvenorSeries C
ORI Healthcare FundSeries A, Series B
Ohio Innovation FundSeries A, Series B, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2026

    Developing a digital companion solution for enFuse with Aptar Digital Health.

  • Apr 9, 2026

    Partnering with Aptar Digital Health on a digital companion solution.

Enable Injections Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Enable Injections Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Enable Injections's valuation, stock price, and market status.

Firmographic Details

HeadquartersCincinnati, Ohio
Employee Range205
Year Founded2010
Last FundingJan 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.